Sysmex Corp
TSE:6869

Watchlist Manager
Sysmex Corp Logo
Sysmex Corp
TSE:6869
Watchlist
Price: 2 933.5 JPY 0.05% Market Closed
Market Cap: 1.8T JPY
Have any thoughts about
Sysmex Corp?
Write Note

Sysmex Corp
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sysmex Corp
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Sysmex Corp
TSE:6869
Other Operating Expenses
ÂĄ1.5B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
N/A
Terumo Corp
TSE:4543
Other Operating Expenses
-ÂĄ2B
CAGR 3-Years
-105%
CAGR 5-Years
N/A
CAGR 10-Years
-114%
Olympus Corp
TSE:7733
Other Operating Expenses
-ÂĄ60.7B
CAGR 3-Years
-54%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Nihon Kohden Corp
TSE:6849
Other Operating Expenses
-ÂĄ5.2B
CAGR 3-Years
-56%
CAGR 5-Years
-382%
CAGR 10-Years
-119%
JEOL Ltd
TSE:6951
Other Operating Expenses
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fukuda Denshi Co Ltd
TSE:6960
Other Operating Expenses
-ÂĄ1m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sysmex Corp
Glance View

Market Cap
1.8T JPY
Industry
Health Care

In the bustling world of healthcare diagnostics, Sysmex Corporation stands as a beacon of innovation and precision. Originating from the vibrant city of Kobe, Japan, the company has mastered the art of transforming complex scientific processes into streamlined solutions. With roots tracing back to the 1960s, Sysmex emerged as a pioneer in the field of hematology, developing technological marvels that analyze blood components with remarkable accuracy. This precision is not merely an academic pursuit; it translates into actionable insights for medical professionals, empowering them to diagnose and monitor conditions ranging from anemia to leukemia with a high degree of reliability. As the lifeblood of medical laboratories worldwide, Sysmex's automated analyzers and testing systems are indispensable tools in pathologies, enabling swift and accurate patient care. Sysmex's business model is a symphony of product innovation and service excellence. The company thrives by blending advanced technologies with an ever-expanding portfolio of diagnostic instruments and reagents, ensuring that their systems remain both state-of-the-art and user-friendly. Revenue generation for Sysmex is a harmonious balance between instrument sales and the recurring income stream from consumables and after-sales service contracts. This dual approach not only secures initial capital from equipment sales but also ensures sustained engagement with their clients. By investing heavily in research and development, Sysmex continuously pushes the envelope in medical diagnostics, tapping into emerging fields like oncology, hemostasis, and urinalysis. In doing so, it fortifies its position as a global leader, committed to advancing healthcare outcomes through technological innovation and customer-centric practices.

Intrinsic Value
3 013.24 JPY
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Sysmex Corp's Other Operating Expenses?
Other Operating Expenses
1.5B JPY

Based on the financial report for Sep 30, 2024, Sysmex Corp's Other Operating Expenses amounts to 1.5B JPY.

What is Sysmex Corp's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
16%

Back to Top